References

PX’Therapeutics has been working with over 160 biopharmaceutical companies and academic research centres through service based contracts or research collaborations.
            

List of non-confidential clients

• Alfact Innovation (France)
• Alizé Pharma (France)
• BioInfoBank Institute (Pologne)
• BioMérieux (France)
• Bosch i Gimpera Foundation (Spain)
• CEA (France)
• CEREP (France)
• CHU Grenoble (France)
• CNRS (France)
• CRSSA (Ministry of Defence, France)
• Cyclacel (United Kingdom)
• DBMS (Grenoble, France)
• Delta Crystallon (The Netherlands)
• ENS Lyon (France)
• European Synchrotron Research Facility (Grenoble, France)
• ExonHit Therapeutics (France /USA)
• Fovea Pharmaceuticals (France)
• Galderma (France)
• Geneuro (France)
• GenHomme consortium (France)
• Genticel (France)
• GREPI, Research Group on Infl ammatory Process (Grenoble, France)
• Diagnostic Grifols
• Hopital Necker (France)
• Hospital Clínic (Spain)
• ImmunNovative Developments (Spain)


List of partners & collaborators

• CRSSA (Ministry of Defence, France)
• European (Grenoble, France)
• GenHomme consortium (France)
• GREPI, Research Group on Infl ammatory Process (Grenoble, France)

• LFB (France)
• Merck IRBM (Italia)
• Mérial (France)
• Michigan University (USA)
• Mymetics Corp. (USA)
• Netris Pharma (France)
• OPI (France)
• Pangenetics (UK)
• Pronota (Belgium)
• Pfizer (France)
• Sisene (France) )
• Trophos (France)
• TSI (USA)
• University of New South Wales (Australia)
• Viventia h (Canada)
• Clínic Foundation (Spain)
• IGS, &Genomic Data Group (Marseille, France)
• Innate Pharma (France)
• Institute of Stuctural Biology (Grenoble, France)
• INSERM (France)
• INSERM/UJF - Neurodegeneration (France)
• Institut Necker (France)
• Invivogen (France)
• Laboratoire français du fractionnement et des biotechnologies (LFB) (France)
• Oncomax (Russia)





• Institute of Stuctural Biology (Grenoble, France)
• IGS, Structural & Genomic Data Group (Marseille, France)
• IMGT (Montpellier, France)

PX’Therapeutics belongs to the global competitiveness bio-cluster “Lyon Biopole” and is also a member of the Biotech Committee of the LEEM.